Pharmaceuticals

Sleeping Pills Market Outlook: Growth and Forecast Highlights 2030

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sleeping pills market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Sleeping Pills Market in 2030?

The sleeping pills market has experienced significant expansion in recent years. Its size is forecast to grow from $85.87 billion in 2025 to $93.03 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical growth can be linked to the limited availability of sleep disorder treatments, the increasing prevalence of insomnia, the dominance of prescription sleeping pills, traditional pharmacy distribution channels, and low awareness about sleep hygiene.

The sleeping pills market is projected to experience substantial expansion over the coming years. By 2030, its valuation is set to reach $126.55 billion, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is driven by several factors, including the introduction of innovative non-benzodiazepine medications, increased acceptance of melatonin and various herbal supplements, the growing reach of online pharmacies, tailored sleep treatment initiatives, and an enlarging base of elderly and adult consumers. Key developments anticipated during this period encompass a global surge in sleep disorder prevalence, greater use of over-the-counter sleep aids, an intensified focus on personalized sleep therapies, the proliferation of online pharmacies and e-commerce platforms, and heightened awareness regarding natural and herbal sleep supplements.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24704&type=smp

What Drivers Are Influencing Production Trends In The Sleeping Pills Market?

The escalating incidence of mental illness is projected to fuel the expansion of the sleeping pills market moving forward. Mental illness describes a broad spectrum of mental health conditions that impact an individual’s mood, thought processes, behavior, and overall capability. The rise in mental illness prevalence is attributed to increasing levels of chronic stress, as prolonged stress disrupts brain function and can trigger or intensify mental health disorders. Sleeping pills assist in managing mental illness by enhancing sleep quality, which is vital for emotional and cognitive stability. These medications help alleviate symptoms of anxiety and depression by encouraging restful sleep and improving overall mental health and daily performance. For instance, in 2025, according to the National Alliance on Mental Illness and NextStep Solutions Behavioral Health, US-based health agencies reported that serious mental illness (SMI) prevalence was about 5.44% in 2023 and remained close by 2024 at about 5.6% of adults, indicating stability in that severe category. Hence, the increasing prevalence of mental illness is a primary driver for the growth of the sleeping pills market.

Which Segment Groups Are Influencing The Sleeping Pills Market?

The sleeping pills market covered in this report is segmented –

1) By Medication Type: Prescription Sleeping Pills, Over The Counter (OTC) Sleeping Pills

2) By Product Type: Benzodiazepines, Non Benzodiazepines

3) By Sleep Disorder: Insomnia, Sleep Disorder, Restless Leg Syndrome Narcolepsy, Sleepwalking

4) By Consumer Demographics: Age Groups, Gender, Health Conditions

5) By Distribution Channel: Retail Pharmacies, Online Pharmacies, Hospitals And Clinics, Health And Wellness Stores

Subsegments:

1) By Prescription Sleeping Pills: Benzodiazepines, Non-Benzodiazepines, Antidepressants, Antihistamines, Melatonin Receptor Agonists, Orexin Receptor Antagonists

2) By Over The Counter (OTC): Diphenhydramine, Doxylamine, Melatonin Supplements, Valerian Root

Which Trends Are Shaping Activity Within The Sleeping Pills Market?

Leading entities within the sleeping pills market are concentrating on developing advanced compositions, such as novel drug formulations, with the aim of improving sleep quality, reducing the likelihood of dependency, and minimizing adverse reactions. Novel drug formulations involve the creation of new medicinal compounds designed to enhance effectiveness, improve absorption, decrease side effects, and offer more precise and patient-friendly therapeutic options. As an illustration, in October 2024, Neurovalens, a UK-based medical device company, introduced Modius Sleep. This Food and Drug Administration (FDA)-cleared, physician-prescribed medical device is specifically engineered to address chronic insomnia in adults aged 22 and older. It functions by utilizing low-level electrical vestibular nerve stimulation to target the hypothalamus and brainstem, which are critical areas for regulating sleep and circadian rhythms. The device is to be worn on the head for 30 minutes each evening, typically 1–2 hours before bedtime, and features adjustable intensity for the user’s comfort. Modius Sleep is user-friendly, portable, and can be worn while undertaking activities such as reading or watching TV.

Who Are The Major Companies Operating In The Sleeping Pills Market?

Major companies operating in the sleeping pills market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited, Aurobindo Pharma Ltd. , Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Mallinckrodt Pharmaceuticals plc, Idorsia Pharmaceuticals Ltd, Procter & Gamble Health Limited (P&G Health), Allegiant Health

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sleeping-pills-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Sleeping Pills Market?

North America was the largest region in the sleeping pills market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sleeping Pills Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24704&type=smp

Browse Through More Reports Similar to the Global Sleeping Pills Market 2026, By The Business Research Company

Sleep Apnea Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795